Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 4, 2009, Pages 439-443

  Soyinka, Julius O ^a   Onyeji, Cyprian O ^a   Omoruyi, Sharon I ^a   Owolabi, Adegbenga R ^a   Sarma, Pullela V ^b   Cook, James M ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

3 hydroxyquinine; Nevirapine; Pharmacokinetic interaction; Quinine

Indexed keywords

3 HYDROXYQUININE; DRUG METABOLITE; NEVIRAPINE; QUININE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; VALIDATION PROCESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG COMBINATION; DRUG INTERACTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANTI-HIV AGENTS; ANTIMALARIALS; CROSS-OVER STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NEVIRAPINE; QUININE;

EID: 85047683159     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.04.0004     Document Type: Article

References (31)

1. World Health Organization. Malaria and HIV/AIDS interactions and implications: Conclusions of a technical consultation convened by WHO, 23-24 June 2004. Geneva: WHO, 2004.
2. Tracy JW, Webster LT. Drugs used in the chemotherapy of protozoal infections: Malaria. In: Goodman LS et al. eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996: 965-985.
3. Sanjeev K et al. Population pharmacokinetics of intramuscular quinine in children with severe malaria. Antimicrob Agents Chemother 2001; 45: 1803-1809.
4. Adam I et al. Quinine for treatment of chloroquine-resistant falciparum malaria in pregnant and non-pregnant Sudanese women. Ann Trop Med Parasitol 2005; 99: 427-429.
5. Pukrittayakamee S et al. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994; 88: 324-327.
6. Mutanda LN. Assessment of drug resistance to malaria parasite in residents of Kampala, Uganda. East Afr Med J 1999; 76: 191-196.
7. Checkley AM, Whitely CJ. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria? Expert Rev Anti Infect Ther 2007; 5: 199-204.
8. PrayGod G et al. Artemisinin derivative versus quinine in treating severe malaria in children: a systematic review. Malar J 2008; 7: 210.
9. Giao PT, Vries PJ. Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet 2001; 40: 343-373.
10. Diczfalusy U et al. 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. Pharmacogenet Genomics 2008; 18: 201-208.
11. Smith PF et al.Clinical pharmacokinetics of non nucleoside reverse transcriptase inhibitors. Clin Pharmacokinet 2001; 40: 893-905.
12. Von Moltke LL et al. Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors. J Clin Pharmacol 2001; 3: 85-91.
13. Erickson DA et al. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos 1999; 27: 1488-1495.
14. Lamson M et al. Nevirapine induces both CYP3A4 and CYP2B6 metabolic pathways. Clin Pharmacol Ther 1999; 65: 137.
15. Back D et al. Pharmacokinetic drug interactions with nevirapine. J Acquir Immune Defic Syndr 2003; 14(Suppl): 591-600.
16. Concepta AM. Drug interaction between Coartem® and nevirapine, efavirenz or rifampicin in HIV positive Ugandan patients. US National institutes of Health Clinical Trials CPR 005, 2008.
17. Babalola CP et al. Column liquid chromatographic analysis of quinine in human plasma, saliva and urine. J Chromatogr 1993; 616: 151-154.
18. Gibaldi M, Perrier D. Pharmacokinetics. New York: Decker, 1982.
19. Babalola CP et al. Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci 1998; 20: 118-122.
20. Mirghani RA et al. Simultaneous determination of quinine and four metabolites in plasma and urine by high performance liquid chromatography. J Chromatogr Biomed Sci Appl 2001; 754: 57-64.
21. Abdelrahim II et al. Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria. J Clin Pharm Ther 2007; 32: 15-19.
22. Kayumba PC et al. Taste-masked quinine sulphate pellets: bioavailability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. Ann Trop Paediatr 2008; 28: 103-109.
23. Zhao XJ et al. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by humanlike microsomes and nine recombinant human cytochromes P450. J Pharmacol Exp Ther 1996; 279: 1321-1334.
24. Boehringer Ingelheim. Viramune: Summary of Product Characteristics, 2001.
25. Moreno A et al. Concomitant use of non-nucleoside reverse transcriptase inhibitors does not decrease the inhibitory quotient of dual ritonavir/indinavir-based therapy. Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, USA, 2001, Abstract 1728.
26. Choudey N et al. Importance of NNRTIs on the pharmacokinetics of amprenavir and ritonavir in HIV-infected patients. Presented at the 2nd International Workshop on Clinical Pharmacology of HIV Therapy, Nordwijk, The Netherlands. 2001, Abstract 1.12.
27. Veidkamp AI et al. High exposure to nevirapine in plasma is associated to an improved virological response in HIV-1-infected individuals. AIDS 2001; 15: 1089-1095
28. Clarke SM et al. Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis 2001; 33: 1595-1597.
29. Kappelhoff BS et al. Practical guidelines to interpret plasma concentrations of antiretroviral drugs. Clin Pharmacokinet 2004; 43: 845-853.
30. Jaruratanasirikul S, Sriwiriyajan S. Pharmacokinetic study of the interaction between itraconazole and nevirapine. Eur J Clin Pharmacol 2007; 63: 451-456.
31. Geilling EM, Kelsey FE. Metabolism of quinine. Naunyn Schmiedebergs Arch Pharmacol 2004; 205: 167-169.